CompletedPhase 1ACTRN12607000248460

Comprehension of medicine label instructions - a pilot study in glaucoma patients.

Are large print labels, on eye medications, required by glaucoma patient's to assist their comprehension of prescribed treatment?


Sponsor

Catherine Rokhahr, Pharmacy, Royal Victorian Eye and Ear Hospital.

Enrollment

200 participants

Start Date

Apr 1, 2007

Study Type

Interventional

Conditions

Summary

Main purpose of this study is to identify if there is a need to offer of a large print label, on eye medications, to glaucoma patients that display certain visual function and disease characteristics. In turn, this may assist these patients in adhering to their prescribed treatment.


Eligibility

Sex: Both males and femalesMin Age: 18 YearssMax Age: 100 Yearss

Plain Language Summary

Simplified for easier understanding

This pilot study examines how well glaucoma patients understand the instructions on their eye drop medication labels. It is for adults aged 18 to 100 who use prescription eye drops and have not had their eyes dilated at their clinic visit. Participants complete a short assessment about how they interpret medication label directions.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Written informed consent will be obtained from all paricipants. Participants will have their near vision assessed with their usual correction / glasses. Thirdly, they will be asked to recall their

Written informed consent will be obtained from all paricipants. Participants will have their near vision assessed with their usual correction / glasses. Thirdly, they will be asked to recall their own eye medication use; name, dose and instructions for use for each. Finally, they will be asked 3 repeat questions on 4 sample eye drop labels. The questions are structured to allow identification of "the name of the medicine", "which eye the medicine is for" and "how often the medicine should be used". Answers will be recorded as either correct or incorrect. Participants will be presented 2 standard and 2 large print labels in a set format and permitted a few minutes to examine each before being questioned. Assessment time approximately 5-10 minutes.


Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12607000248460